Resources for Health Systems, Health Care Providers, and Researchers

Find resources for health systems, health care providers, and researchers on dementia risk reduction, detection and diagnosis, treatment and care, ALZ-NET operations, and more.

Prevention and risk reduction

This section contains resources to support public health education.

Assessment, detection, and diagnosis

This section contains resources specific to the assessment tools and diagnostics that could support clinicians. There are a variety of tools and tests available, ALZ-NET will require some specific assessments to be documented and resources for these are denoted below.

Cognitive and functional assessments


Biofluid analysis

Cerebrospinal Fluid

Blood and Plasma

Genetic testing

Treatment and comprehensive care

This section contains resources focused on treatment delivery, management, and dementia memory care.

FDA-approved amyloid targeting treatments tracked in ALZ-NET

Aduhelm® (aducanumab)

Aducanumab is being discontinued. Patients who are now receiving it by prescription will have it available to them until Nov. 1, 2024.

Kisunla™ (donanemab)

Leqembi® (lecanemab)

FDA-approved neuropsychiatric treatments tracked in ALZ-NET

Rexulti® (brexpiprazole)

Comprehensive care

Person-centered care and communication

This section contains resources focused on the journey map of patient experience.

Medicare and billing

ALZ-NET operations

All resources related to ALZ-NET operations are managed by the American College of Radiology.

Additional Alzheimer’s Association resources

Browse information, tools and resources for those working in the field of Alzheimer’s and dementia care, including for health systems, medical and health care professionals, professional care providers and public health professionals.

For any additional resources,

  • Clinical education training: The Association offers a number of online Alzheimer’s and dementia courses for scientists, clinicians, physicians, and dementia professionals.
  • Research webinars and training: Join the Alzheimer’s Association and ISTAART for a series of webinars that share the latest advances in Alzheimer's and dementia research and career development strategies.
  • Public health training: The Association is your source for online courses about public health and dementia for public health students, educators, and professionals.
  • Future scientific meetings: Attend an upcoming in-person or virtual conference to learn and network within the dementia science community – one of the many year-round opportunities offered by the Alzheimer’s Association.
  • ISTAART: The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) is an inclusive global network of scientists, clinicians, and dementia professionals. Members of this professional organization share common goals: the pursuit of knowledge, collaboration, and breakthroughs to advance the research and treatment of Alzheimer’s disease and other dementias.
  • ISTAART Voices: ISTAART Voices is a new podcast that navigates the intricate world of dementia research, practice, and treatment. Join us as we explore the latest research in conversation with study authors from the Alzheimer’s & Dementia® journal family. You can earn Continuing Medical Education (CME) and Continuing Education (CE) at no cost when you listen to this podcast.
  • Funding opportunities: The Alzheimer’s Association is the world’s largest non-profit funder of Alzheimer’s and dementia science. The Alzheimer’s Association International Research Grant Program (IRGP) supports Alzheimer’s and dementia researchers at every professional stage and includes categories aimed at addressing research gaps.